Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABBV | Common Stock, $0.01 par value | Options Exercise | $5.34M | +87.1K | +16.97% | $61.36* | 600K | Jul 17, 2024 | Direct | |
transaction | ABBV | Common Stock, $0.01 par value | Options Exercise | $9.44M | +119K | +19.9% | $79.02* | 720K | Jul 17, 2024 | Direct | |
transaction | ABBV | Common Stock, $0.01 par value | Options Exercise | $7.14M | +76.4K | +10.61% | $93.50 | 796K | Jul 17, 2024 | Direct | |
transaction | ABBV | Common Stock, $0.01 par value | Sale | -$49.5M | -283K | -35.54% | $175.00 | 513K | Jul 17, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ABBV | Option (Right To Buy) | Options Exercise | $0 | -87.1K | -100% | $0.00* | 0 | Jul 17, 2024 | Common Stock | 87.1K | $61.36 | Direct | F1 |
transaction | ABBV | Option (Right To Buy) | Options Exercise | $0 | -119K | -66.67% | $0.00 | 59.7K | Jul 17, 2024 | Common Stock | 119K | $79.02 | Direct | F1 |
transaction | ABBV | Option (Right To Buy) | Options Exercise | $0 | -76.4K | -33.33% | $0.00 | 153K | Jul 17, 2024 | Common Stock | 76.4K | $93.50 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |
The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).